DanCann Pharma was founded in 2018 and is a Danish pharmaceutical biotechnology company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed cultivation and distribution company based in Denmark. The company focuses on discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in a wide range of disease areas.
As a company, we work with a clear vision to improve health and quality of life for patients with challenges with the dream of creating tomorrows new cannabis- and cannabinoid-based pharmaceuticals by focusing on patented and differentiated innovative drug administration systems.
